Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
暂无分享,去创建一个
V. Calvez | C. Charpentier | C. Katlama | D. Descamps | K. Lacombe | V. Joly | R. Palich | R. Landman | L. Morand‐Joubert | A. Marcelin | C. Soulié | S. Lambert-Niclot | A. Storto | J. Ghosn | M. Wirden | V. Ferré